WallStreetZenWallStreetZen

NASDAQ: ATYR
Atyr Pharma Inc Stock Ownership - Who owns Atyr Pharma?

Insider buying vs selling

Have Atyr Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Nancy DenyesGeneral Counsel2024-06-055,000$1.86
$9.28kBuy
Sanjay ShuklaPresident and CEO2024-05-3120,000$1.81
$36.14kBuy
Jill Marie BroadfootChief Financial Officer2024-05-315,000$1.79
$8.95kBuy
Timothy CoughlinDirector2024-05-3050,000$1.75
$87.50kBuy
Jill Marie BroadfootChief Financial Officer2024-02-061,590$1.69
$2.69kSell
Sanjay ShuklaPresident and CEO2023-12-1212,000$1.18
$14.14kBuy
Sanjay ShuklaPresident and CEO2023-12-113,000$1.17
$3.51kBuy
Sanjay ShuklaPresident and CEO2023-11-1313,578$1.11
$15.09kBuy
Sanjay ShuklaPresident and CEO2023-11-101,422$1.14
$1.62kBuy
Sanjay ShuklaPresident and CEO2023-07-2815,000$2.02
$30.23kBuy

1 of 1

ATYR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATYR insiders and whales buy or sell their stock.

ATYR Shareholders

What type of owners hold Atyr Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Federated Hermes Inc14.74%10,169,600$18.81MInstitution
Fmr LLC12.93%8,923,210$16.51MInstitution
Logos Global Management LP4.49%3,100,000$5.74MInstitution
Vanguard Group Inc3.84%2,652,157$4.91MInstitution
Tikvah Management LLC3.57%2,460,833$4.55MInstitution
Citadel Advisors LLC2.76%1,903,346$3.52MInstitution
Sofinnova Venture Partners Ix LP2.70%1,866,126$3.45MInsider
Srinivas Akkaraju2.70%1,866,126$3.45MInsider
Amir Nashat2.67%1,840,564$3.41MInsider
Polaris Venture Management Co V LLC2.65%1,827,992$3.38MInsider

1 of 3

ATYR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATYR60.58%22.26%Net BuyingNet Buying
CRVS28.60%47.75%Net BuyingNet Buying
NVCT8.51%49.77%Net BuyingNet Buying
ANL0.05%0.00%
HOWL51.91%48.09%

Atyr Pharma Stock Ownership FAQ

Who owns Atyr Pharma?

Atyr Pharma (NASDAQ: ATYR) is owned by 60.58% institutional shareholders, 22.26% Atyr Pharma insiders, and 17.16% retail investors. Sofinnova Venture Partners Ix LP is the largest individual Atyr Pharma shareholder, owning 1.87M shares representing 2.70% of the company. Sofinnova Venture Partners Ix LP's Atyr Pharma shares are currently valued at $3.42M.

If you're new to stock investing, here's how to buy Atyr Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.